The company has demonstrably boosted the development of an novel therapy for amyloid heart disease, employing the investigational drug. Early clinical results suggests promising benefits for those diagnosed by this https://biotech356641.blogpayz.com/42416786/bridgebio-improves-amyloidosis-therapy-using-the-therapy